Results 231 to 240 of about 316,749 (274)

In-stent restenosis.

Italian heart journal : official journal of the Italian Federation of Cardiology, 2001
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire   +4 more sources

In-stent restenosis in vertebral artery stenting

Neuroradiology, 2007
Sir, Tsutsumi et al. reported the clinical and angiographic data on 12 patients receiving stent deployment for symptomatic ostial vertebral artery (VA) stenosis [1]. The in-stent re-stenosis (ISR) rate was surprising low – 0% angiographic restenosis at 12 months and 8% after a mean of 31.5 months clinical/radiological follow-up.
Yen-Hung, Lin, Hsien-Li, Kao
openaire   +2 more sources

Treatment of in-stent restenosis

International Journal of Cardiology, 2005
Since its introduction in 1977, percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease by providing a safe and feasible alternative to coronary bypass graft (CABG) surgery [1]. The subsequent development of coronary stents has had a further positive impact on the clinical effectiveness and predictability of
Thuraia, Nageh, Bernhard, Meier
openaire   +2 more sources

Pathology of in-stent restenosis

Current Opinion in Lipidology, 1999
The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis.
R, Virmani, A, Farb
openaire   +2 more sources

Restenosis after carotid artery stenting

Vascular, 2017
As a common etiology for ischemic stroke, atherosclerotic carotid stenosis has been targeted by vascular surgery since 1950s. Compared with carotid endarterectomy, carotid angioplasty and stenting (CAS) is almost similarly efficacious and less invasive. These advantages make CAS an alternative in treating carotid stenosis.
Zhengze, Dai, Gelin, Xu
openaire   +2 more sources

Mechanisms of drug-eluting stent restenosis

Cardiovascular Intervention and Therapeutics, 2020
J. Aoki, K. Tanabe
semanticscholar   +1 more source

IN-STENT RESTENOSIS

2015
Koroner girisimlerde stentlerin kullanılması koroner arter hastalıgının tedavisini dramatik olarak degistirmistir. Ancak bu girisim sıklıkla restenoz adı verilen bir süreçle sınırlanmaktadır. Restenozun özellikle fokal restenozların ilk tedavi seçenegi tekrarlayan balon anjiyoplastilerdir.
KARAKAYA, Osman, ESEN, Ali Metin
openaire   +1 more source

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.

JACC: Cardiovascular Interventions, 2018
F. Alfonso, M. Pérez-Vizcayno, J. Cuesta, B. García del Blanco, A. García-Touchard, J. López-Mínguez, M. Masotti, J. Zueco, Á. Cequier, M. Velázquez, R. Moreno, V. Mainar, Antonio J Domínguez, C. Morís, E. Molina, F. Rivero, P. Jiménez-Quevedo, N. Gonzalo, C. Fernández-Pérez   +18 more
semanticscholar   +1 more source

Restenosis After Carotid Artery Stenting

Cardiovascular Revascularization Medicine, 2021
Ehrin J, Armstrong, Damianos G, Kokkinidis   +1 more
openaire   +2 more sources

In-stent restenosis

The American Journal of Cardiology, 2002
openaire   +2 more sources